Prognostic Value of the Estimated Glomerular Filtration Rate Decline in Hypertensive Patients Without Chronic Kidney Disease

American Journal of Hypertension
Gabriel Coll-de-TueroMarc Saez

Abstract

Our objective of this study was to determine if rate of estimated glomerular filtration rate (eGFR) decline and its intensity was associated with cardiovascular risk and death in patients with hypertension whose baseline eGFR was higher than 60 ml/minute/1.73 m2. This study comprised 2,516 patients with hypertension who had had at least 2 serum creatinine measurements over a 4-year period. An eGFR reduction of ≥10% per year has been deemed as high eGFR and a reduction in eGFR of less than 10% per year as a low decline. The end points were coronary artery disease, stroke, transitory ischemic accident, peripheral arterial disease, heart failure, atrial fibrillation, and death from any cause. Cox regression analyses adjusted for potentially confounding factors were conducted. A total of 2,354 patients with low rate of eGFR decline and 149 with high rate of eGFR decline were analyzed. The adjusted model shows that a -10% rate of eGFR decline per year is associated with a higher risk of the primary end point (HR 1.9; 95% CI 1.1-3.5; P = 0.02) and arteriosclerotic vascular disease (HR 2.2; 95% CI 1.2-4.2; P < 0.001) in all hypertensive groups. The variables associated to high/low rate of eGFR decline in the logistic regression model ...Continue Reading

References

Oct 25, 2002·Journal of the American Society of Nephrology : JASN·J Hunter YoungJosef Coresh
Oct 2, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Nicholas DreyMary Rogerson
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Linda F FriedAnne B Newman
Sep 15, 2007·Journal of the American Society of Nephrology : JASN·Ann M O'HareC Seth Landefeld
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Aug 29, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Hiroki YokoyamaMasakazu Haneda
Nov 7, 2009·Journal of the American Society of Nephrology : JASN·Kunihiro MatsushitaJosef Coresh
Nov 7, 2009·Journal of the American Society of Nephrology : JASN·Michael G ShlipakMark J Sarnak
Mar 17, 2010·Medicina clínica·Alejandro López-SuárezPablo Gómez-Fernández
Jan 25, 2013·Kidney International·Tanvir C TurinBrenda R Hemmelgarn
Sep 12, 2013·Nephron. Clinical Practice·Indranil DasguptaUNKNOWN NICE Hyperphosphataemia Guideline Development Group
Jun 4, 2014·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Sep 13, 2014·Journal of the American Heart Association·Tanvir Chowdhury TurinBrenda R Hemmelgarn
Dec 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hiddo J Lambers HeerspinkLesley A Inker
Feb 28, 2015·Journal of Epidemiology and Community Health·Xianhui QinFanfan Hou
Apr 1, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Casey M RebholzJosef Coresh
Apr 23, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Enayet K ChowdhuryUNKNOWN Second Australian National Blood Pressure Study Management Committee
Oct 11, 2015·International Journal of Cardiology·Tanvir C TurinBrenda R Hemmelgarn
Dec 15, 2015·Journal of the American Society of Nephrology : JASN·David M J NaimarkUNKNOWN CKD Prognosis Consortium
Mar 2, 2017·BMC Nephrology·Bjørn O EriksenToralf Melsom

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.